1.3. Analysis.
Comparison 1 Adults using 160/4.5 mcg BDF single inhaler therapy versus current best practice, Outcome 3 Fatal serious adverse events (fatal).
Comparison 1 Adults using 160/4.5 mcg BDF single inhaler therapy versus current best practice, Outcome 3 Fatal serious adverse events (fatal).